Responses
EULAR 2014: Scientific Abstracts
Abstracts accepted for publication. Psoriatic arthritis
AB0746 Apremilast, an Oral Phosphodiesterase 4 Inhibitor, and the Impact of Baseline Weight and BMI on ACR20 and HAQ-DI Response: Pooled Results from 3 Phase 3, Randomized, Controlled Trials
Compose a Response to This Article
Other responses
No responses have been published for this article.